Clinical Trial Update: Study of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating perioperative NP137 in combination with FOLFIRINOX for resectable pancreatic cancer; the study is currently not yet rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• FOLFIRINOX
• NP137

Snippet

Sponsor: Aram Hezel | Conditions: Pancreatic Cancer | Phase 1 | Status: NOT_YET_RECRUITING